Ekaterinburg, Ekaterinburg, Russian Federation
Yekaterinburg, Ekaterinburg, Russian Federation
Yekaterinburg, Ekaterinburg, Russian Federation
UDC 616.31
Introduction. Odontogenic infection acts as a key trigger in the pathogenesis of medication- related osteonecrosis of the jaw. Poor oral hygiene exacerbates the situation – foci of chronic odontogenic infection become decompensated, periodontal diseases progress, leading to tooth loss and the emergence of new sources of osteonecrosis. Chronic oral inflammation makes proper oral hygiene and dental restoration impossible, which is one of the causes of social maladjustment for the patient. Objective: to evaluate the oral cavity condition in patients with drug-associated osteonecrosis of the jaw before and after complex treatment. Materials and Methods. A case-control study. 79 patients with medication-related osteonecrosis of the jaw were examined. All patients were treated according to the proposed protocol, which included intraoperative determination of sequestrectomy margins using laser Doppler flowmetry, treatment of residual granulations with a red diode laser, and injections of autologous plasma into the edges of the postoperative wound. The dental status of patients was assessed using the following indices: the caries intensity index, the Simplified Oral Hygiene Index, and the Papillary-Marginal-Alveolar Index (1960). The indices were calculated according to standard methods. Calculations for statistical analysis were performed using the MS Excel 10 Analysis ToolPak and Statistica 10. Results. Pathology of the hard tissues of all tooth groups was identified in all patients. The prevalence of caries was 100 %. The caries intensity index in the study group was 20.06 ±5.58, with 11.4 % of patients having complete secondary edentulism. The mean Simplified Oral Hygiene Index by Greene-Vermillion was 2.5 ±0.07. The mean Papillary-Marginal-Alveolar Index was 54.67 ±15.65. The dynamics of dental indicators were assessed 2 months after treatment. The caries intensity index increased (22.08 ±5.17), the mean Oral Hygiene Index score was 1.61 ±0.5, and the Papillary-Marginal-Alveolar Index decreased by 15.03 % (39.64 ±16.24). In 50.6 % of patients, the integrity of the dentition was restored using removable orthopedic prostheses. Conclusion. Thus, the proposed method for the intraoperative determination of sequestrectomy boundaries and the algorithm for postoperative management and early rehabilitation of patients with medication-related osteonecrosis of the jaw makes it possible to alleviate pain, eliminate the mucosal defect of the alveolar process, perform a complete oral debridement, and restore the integrity of the dentition with orthopedic prostheses.
medication-related osteonecrosis of the jaw, bone-modifying agents, oral hygiene, method of intraoperative determination of sequestrectomy boundaries, algorithm for patient rehabilitation
1. Kühl S., Walter C., Acham S., Pfeffer R., Lambrecht J.T. Bisphosphonate-related osteonecrosis of the jaws-a review. Oral oncology. 2012;48(10):938-947. https://doi.org/10.1016/j.oraloncology.2012.03.028
2. Khan A.A., Morrison A., Hanley D.A., Felsenberg D., McCauley L.K., O'Ryan F. et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. Journal of Bone and Mineral Research. 2015;30(1):3-23. https://doi.org/10.1002/jbmr.2405
3. Lombard T., Neirinckx V., Rogister B., Gilon Y., Wislet S. Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches. Stem Cells International. 2016;2016:8768162. https://doi.org/10.1155/2016/8768162
4. Anesi A., Generali L., Sandoni L., Pozzi S., Grande A. From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights. International journal of molecular sciences. 2019;20(19):4925. https://doi.org/10.3390/ijms20194925
5. De Sousa Ferreira V.C., Lopes A.P., Alves N.M., Sousa F.R.N., Pereira K.M.A., Gondim D.V. et al. Bisphosphonate-related osteonecrosis induced change in alveolar bone architecture in rats with participation of Wnt signaling. Clinical oral investigations. 2021;25(2):673-682. https://doi.org/10.1007/s00784-020-03551-7
6. Hayano H., Kuroshima S., Sasaki M., Tamaki S., Inoue M., Ishisaki A. et al. Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice. Bone. 2020;135:115308. https://doi.org/10.1016/j.bone.2020
7. Kawahara M., Kuroshima S., Sawase T. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. International journal of implant dentistry. 2021;7(1):47. https://doi.org/10.1186/s40729-021-00323-0
8. Kato S., Takashima H., Furuno S., Kako M., Maeda M., Hishida S. et al. A retrospective study on the incidence and risk factor of ARONJ. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2021;33(5):489-493. https://doi.org/10.1016/j.ajoms.2021.02.011
9. AlRowis R., Aldawood A., AlOtaibi M., Alnasser E., AlSaif I., Aljaber A. et al. Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies. The Saudi dental journal. 2022;34(3):202-210. https://doi.org/10.1016/j.sdentj.2022.01.003
10. Gkouveris I., Hadaya D., Soundia A., Bezouglaia O., Chau Y., Dry S.M. et al. Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ). Bone. 2019;123:234-245. https://doi.org/10.1016/j.bone.2019.03.031
11. Hong B.Y., Sobue T., Choquette L., Dupuy A.K., Thompson A., Burleson J.A. et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome. 2019;7(1):66. https://doi.org/10.1186/s40168-019-0679-5
12. Zadik Y. Clarithromycin as the empiric antibiotic therapy for medication-related osteonecrosis of the jaw in multiple myeloma patients. Oral oncology. 2018;84:104-105. https://doi.org/10.1016/j.oraloncology.2018.07.016
13. Bagrova S.G., Kopp M.V., Kutukova S.I., Manzyuk L.V., Semiglazova T.Yu. Ispol'zovanie osteomodificiruyuschih agentov (OMA) dlya profilaktiki i lecheniya patologii kostnoy tkani pri zlokachestvennyh novoobrazovaniyah. Malignant tumours. 2020;10(3s2-2):35-44. [Bagrova S.G., Kopp M.V., Kutukova S.I., Manzyuk L.V., Semiglazova T.Yu. The use of osteomodifying agents (OMA) for the prevention and treatment of bone tissue pathology in malignant neoplasms. Malignant tumours. 2020;10(3s2-2):35-44. (In Russ.)]. https://doi.org/10.18027/2224-5057-2020-10-3s2-38
14. Vinogradova N.G., Haritonova M.P., L'vov K.V., avtory; Municipal'noe avtonomnoe uchrezhdenie «Central'naya gorodskaya klinicheskaya bol'nica № 23», patentoobladatel'. Sposob lecheniya medikamentozno associirovannogo osteonekroza chelyusti. Rossiyskaya Federaciya patent RU 2745476. Opubl. 25.03.2021. [Vinogradova N.G., Kharitonova M.P., Lvov K.V., inventors; Municipal Autonomous Institution "Central City Clinical Hospital No. 23", assignee. Method for the treatment of drug-associated osteonecrosis of the jaw. Russian Federation patent RU 2745476. Published: 25.03.2021. (In Russ.)]. https://elibrary.ru/item.asp?id=45807537
15. Vinogradova N.G., Haritonova M.P., L'vov K.V. Primenenie diodnogo lazera pri lechenii medikamentoznoassociirovannogo osteonekroza chelyusti (klinicheskiy sluchay). Problemy stomatologii. 2021;17(3):64-68. [Vinogradova N.G., Kharitonova M.P., L'vov K.V. The use of a diode laser in the treatment of drug-associated osteonecrosis of the jaw (clinical case). Actual problems in dentistry. 2021;17(3):64-68. (In Russ.)]. https://doi.org/10.18481/2077-7566-21-17-3-64-68
16. Ahmadeeva L.R., Teregulova D.R. Trevozhnye i depressivnye sostoyaniya i ih svyaz' s bolevym sindromom u pacientov, nahodyaschihsya na stacionarnom lechenii. Problemy zhenskogo zdorov'ya. 2012;7(2):23–28. [Akhmadeeva L.R., Teregulova D.R. Anxious and depressive states and their relation to the pain syndrome in hospitalized patients. Problemy ženskogo zdorovʹâ. 2012;7(2):23–28. (In Russ.)]. https://www.elibrary.ru/item.asp?id=17879063
17. Volkov E.A., Yanushevich O.O., red. Terapevticheskaya stomatologiya. V 3 ch. Ch. 1, Bolezni zubov. Moskva: GEOTAR-Media; 2012. 167 s. [Volkov E.A., Yanushevich O.O., eds. Therapeutic dentistry. In 3 pt. Pt 1, Diseases of the teeth. Moscow: GEOTAR-Media; 2012. 167 p. (In Russ.)].
18. Yanushevich O.O., Dmitrieva L.A., red. Parodontologiya. Nacional'noe rukovodstvo. 2-e izd., pererab. i dop. Moskva: GOETAR-Media; 2018. 751 s. (Nacional'nye rukovodstva). [Yanushevich O. O., Dmitrieva L. A., eds. Periodontology. National guidelines. 2nd ed., revised and enlarged. Moscow: GOETAR-Media; 2018. 751 p. (National guidelines). (In Russ.)].
19. Vinogradova N.G., Haritonova M.P., L'vov K.V. Analiz pokazateley kachestva zhizni u pacientov s diagnozom bisfosfonatnyy osteonekroz. Ural'skiy medicinskiy zhurnal. 2019;(7):90-94. [Vinogradova N.G., Kharitonov M.P., Lvov K.V. Analysis of quality of life indicators in patients diagnosed with bisphosphonate osteonecrosis. Ural Medical Journal. 2019;(7):90-94. (In Russ.)]. https://www.elibrary.ru/item.asp?id=38936710
